Search clinical trials for: Zofran ODT (ondansetron 8 mg) without water

Total 49 results

Aquestive Therapeutics

Completed

Three-way Crossover Study Comparing Ondansetron ODFS Administered With and Without Water to Zofran ODT Without Water

Healthy Participants
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Pharmacokinetics of Two Eletriptan Oral Formulations Given With and Without Water and the Commercial Tablet Formulation Given With Water

Healthy Volunteers

Singapore
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg

Healthy

United States
Par Pharmaceutical, Inc.
Algorithme Pharma Inc

Completed

Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fed Conditions

Healthy
Par Pharmaceutical, Inc.
Algorithme Pharma Inc

Completed

Bioavailability Study of Ondansetron 24 mg Orally Disintegrating Tablets Under Fasting Conditions

Healthy

Canada
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Bioequivalence Study of Doxazosin 4 Mg Orally-Disintegrating Tablet With Or Without Water To Doxazosin 4 Mg Japanese Marketed Immediate Release Tablet Under Fasted Condition

Hypertension

Japan
Halozyme Therapeutics

Completed

Phase 1 Safety, Tolerability and PK Study of Ondansetron and Hylenex Recombinant in Healthy Volunteers

Healthy

United States
MonoSol Rx

Completed

Crossover Study Comparing Ondansetron Orally Dissolving Film Strip (ODFS) With Zofran Orally Disintegrating Tablets (01905/08-09)

Nausea With Vomiting Chemotherapy-Induced | Nausea and Vomiting, Postoperative

India
Otsuka Pharmaceutical Co., Ltd.

Completed

Bioequivalence Study of Brexpiprazole Orally Disintegrating Tablets (ODT) 2mg

Healthy Adult Male

Japan
Par Pharmaceutical, Inc.
Algorithme Pharma Inc

Completed

Bioavailability Study of Ondansetron 16 mg Orally Disintegrating Tablets Under Fasting Conditions

Healthy

Canada
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fed Condition

Fed

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fasting Condition

Fasting State

India
MonoSol Rx

Completed

Two Way Bioequivalence Study Under Fed Conditions

Healthy

India
Medical University of Gdansk

Completed

Droperidol and Cardiac Repolarization

Cardiac Repolarization

Poland
Par Pharmaceutical, Inc.
Algorithme Pharma Inc

Completed

Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fasting Conditions

Healthy
Sandoz

Completed

To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Fasting Conditions

Nausea | Vomiting
AstraZeneca

Completed

Study to Assess the Bioavailability of Ticagrelor OD Tablet vs. IR Tablet

Healthy Subjects | Bioavailability

Germany
Sandoz

Completed

To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Non-Fasting Conditions

Nausea | Vomiting
General Hospital of Ningxia Medical University

Completed

Ondansetron for Postspinal Anesthesia Hypotension

Adverse Effect

China
Northwell Health

Withdrawn

Aprepitant PO vs Ondansetron IV for Prevention of Postoperative Nausea and Vomiting

Postoperative Nausea and Vomiting

United States
AstraZeneca

Completed

Study to Assess the Bioequivalence Between Ticagrelor Orodispersible Tablets and Ticagrelor Immediate-release Tablets in Japanese Subjects

Pharmacokinetics | Bioequivalence | Healthy Japanese Subjects

United Kingdom
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Ondansetron Tablets 24 mg and Zofran® Tablets 24 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Ondansetron Tablets 24 mg and Zofran® Tablets 24 mg

Healthy

United States
Bankole Johnson
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Combined Pharmacotherapies for Alcoholism

Alcoholism

United States
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study for Ondansetron Hydrochloride Tablets 8 mg Under Fasting Condition

Healthy

India
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study for Ondansetron Hydrochloride Tablets 8 mg Under Fed Condition

Healthy

India
Spectrum Health - Lakeland
Michigan State University

Completed

A Cohort Study Evaluating the Efficacy of PO Magnesium in the Treatment of Acute Traumatic Brain Injury in Adolescents

Concussion Post Syndrome

United States
Genuine Research Center, Egypt
Adwia Pharma, Egypt

Not yet recruiting

This Study Will Assess the Efficacy and Safety of Ondansetron Compared to Metoclopramide in the Management of Nausea and Vomiting in Adult Patients With Acute Gastroenteritis.

Gastroenteritis
Umeå University
University of California; Mead Johnson Nutrition

Active, not recruiting

Effect of Infant Formula With Bovine Lactoferrin and Low Iron Concentration on Infant Health and Immune Function (LIME)

Health of Formula-fed Children | Infant Infections in Formula-fed Children | Iron Status of Formula-fed Children

Sweden
Theodor Bilharz Research Institute
Cairo University

Unknown

Palonosetron Versus Ondansetron for PONV Prevention in Patients Undergoing ERCP

Postoperative Nausea and Vomiting | Antiemetic
Medical University of South Carolina
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Effectiveness of Naltrexone and/or Ondansetron to Reduce Craving for Alcohol and Drinking

Alcohol Dependence

United States
University of Calgary

Not yet recruiting

Study of Ondansetron in the Prevention of Sleep Syncope: The Nineth Prevention of Syncope Trial (POST9) (POST9)

Sleep Syncope

Canada
Helsinn Healthcare SA

Active, not recruiting

Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk) (CINV)

Chemotherapy-induced Nausea and Vomiting

Spain, Germany, Switzerland, China, Czechia, United Kingdom, Greece
Bagcilar Training and Research Hospital

Completed

Palonosetron vs. Ondansetron for Postoperative Nausea and Vomiting in Bariatric Surgery

Pain, Postoperative | Nausea, Postoperative | Vomiting, Postoperative | Patient Reported Outcomes | Antiemetics

Turkey
Merck Sharp & Dohme LLC

Completed

Aprepitant and Fosaprepitant Time-on-Target PET (Positron Emission Tomography) Study (0869-183)

Chemotherapy-Induced Nausea and Vomiting (CINV)
Indonesia University

Completed

Comparison Between Ondansetron 8 mg and Lidocain 40 mg in Preventing Pain Due to Propofol Injection

General Anesthesia With Propofol

Indonesia
Stanford University
National Institute on Drug Abuse (NIDA)

Completed

5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Physical Dependence

Opioid Withdrawal | Physical Dependence

United States
Merck Sharp & Dohme LLC

Completed

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208)

Chemotherapy Induced Nausea and Vomiting
Stanford University

Completed

Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA

Breast - Female

United States
Rigshospitalet, Denmark
Glostrup University Hospital, Copenhagen

Completed

The Effect of Intraoperative Ketamine on Opioid Consumption and Pain After Spine Surgery in Opioid-dependent Patients

Chronic Pain | Postoperative Pain | Analgesics

Denmark
Maastricht University

Completed

Natural Compounds to Reduce Nitrite in Meat Products (PHYTOME)

Colon Cancer

Netherlands
Merck Sharp & Dohme LLC

Completed

A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC) (KMEC)

Nausea | Vomiting
British Columbia Cancer Agency
Hoffmann-La Roche

Active, not recruiting

Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment (LYTPET)

Lymphoma, Non-Hodgkin | Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Canada
Lundquist Institute for Biomedical Innovation at...
Abbott Nutrition; DaVita Dialysis

Completed

Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients (AIONID)

Inflammation | Oxidative Stress | Hypoalbuminemia | Protein-energy Malnutrition | Chronic Kidney Disease (CKD) Hemodialysis

United States
Stony Brook University

Completed

Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve Gastrectomy

Laparoscopic Sleeve Gastrectomy | Post-operative Nausea and Vomiting

United States
QuantumLeap Healthcare Collaborative

Recruiting

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer (I-SPY)

Breast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast Cancer

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Terminated

Rolapitant Hydrochloride in Preventing Nausea/Vomiting in Patients With Sarcoma Receiving Chemotherapy

Locally Advanced Sarcoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Withdrawn

Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer

Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditions

United States

Search clinical trials for: Zofran ODT (ondansetron 8 mg) without water

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations